| IGCEX | MEDFX | IGCEX / MEDFX | |
| Total Expense Ratio | 1.70 | 1.06 | 160% |
| Annual Report Gross Expense Ratio | 2.59 | 1.07 | 242% |
| Fund Existence | 5 years | 17 years | - |
| Gain YTD | 13.067 | 10.341 | 126% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.6M | 7.63B | 0% |
| Annual Yield % from dividends | 4.51 | 5.09 | 89% |
| Returns for 1 year | 12.91 | 10.52 | 123% |
| Returns for 3 years | 33.06 | 34.57 | 96% |
| Returns for 5 years | 7.64 | 10.44 | 73% |
| Returns for 10 years | N/A | 46.79 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IYSYX | 19.07 | 0.17 | +0.90% |
| Macquarie Smid Cap Core Fund Class Y | |||
| BBGLX | 28.06 | 0.16 | +0.57% |
| Bridge Builder Large Cap Growth | |||
| ALARX | 55.68 | N/A | N/A |
| Alger Capital Appreciation Instl I | |||
| STDFX | 46.91 | N/A | N/A |
| Allspring Large Cap Growth Admin | |||
| LIFLX | 15.67 | N/A | N/A |
| Lord Abbett Focused Large Cap Value I | |||